论文部分内容阅读
目的:观察与探究处方合理性与合理用药指标间的关系。方法:选取2014年03月~2017年03月期间于本院就诊及治疗的100例患者作为研究对象,分析100例患者的处方合理性及其与合理用药相关指标之间的关系。结果:100例患者中,处方不合理占10.00%,处方药物的用法和用量不合理、联合用药不合理、药理拮抗、配伍用药不合理、其他用药不合理分别占6.00%、1.00%、1.00%、1.00%、1.00%;通过分析发现,患者的处方合理性与处方药物的用法、用量不合理、联合用药不合理、药理拮抗、配伍用药不合理、其他用药不合理、性别等合理用药相关指标之间无相关性(p>0.05),患者的处方合理性与年龄、用药花费、药物类别等合理用药相关指标之间存在相关性(p<0.05)。结论:明确处方合理性及其与合理用药相关指标之间的关系十分重要,对于患者的安全治疗具有重要意义。
Objective: To observe and explore the relationship between prescription rationality and reasonable medication index. Methods: A total of 100 patients treated and treated in our hospital from March 2014 to March 2017 were selected as study objects to analyze the rationality of prescription and its relationship with rational drug use-related indexes in 100 patients. Results: Among 100 patients, the prescriptions were irrational accounting for 10.00%, the usage and dosage of prescription drugs were unreasonable, the combination therapy was irrational, the pharmacological antagonism was unreasonable and the other drugs were irrational accounted for 6.00%, 1.00%, 1.00% , 1.00%, 1.00%; Through the analysis found that the patient’s prescription and the rational use of prescription drugs, the amount of unreasonable combination of unreasonable, pharmacological antagonism, incompatible medication unreasonable, unreasonable use of other drugs, gender and other appropriate medication-related indicators (P> 0.05). There was a significant correlation between the reasonableness of prescriptions and the appropriate medication-related factors such as age, medical expense and drug category (p <0.05). Conclusion: It is very important to clarify the rationality of prescription and its relationship with the index of rational drug use, which is of great significance for the safe treatment of patients.